On second thought, the FDA figures it no longer needs to discuss Exelixis’ application for Cabometyx in neuroendocrine tumors ...

It is also under development for the treatment of previously untreated locally recurrent inoperable or metastatic triple negative breast cancer and metastatic high grade neuroendocrine tumors (who ...

She had been diagnosed as having metastatic pulmonary neuroendocrine tumor. The patient's medical and family history was unremarkable; she had, however, smoked more than 20 cigarettes per day for ...

According to GlobalData, Phase II drugs for Neuroendocrine Tumors have a 28% phase transition success rate ... It is also indicated as a second- or third-line treatment for patients with locally ...

M: Metastasis; N: Node; T: Tumor. Data from [21]. Neuroendocrine tumors have demonstrated an increase in incidence and prevalence over the past decades, partly due to increased awareness ...

Carcinoid tumor of midgut origin with large segment ... The resected mass showed signs of hemorrhage within the neuroendocrine metastasis and was associated with clear resection margins (Figure ...

"Our work demonstrates that castrate-resistant neuroendocrine prostate cancer relies on mitochondrial quality control to sustain tumor growth, metastatic potential and cisplatin resistance," notes Dr.

Cancer incidence continues to rise for many common cancers—especially for women. The incidence rate for women younger than 50 ...

Wolin EM, Jarzab B, Eriksson B, et al. Phase III study of pasireotide long-acting release in patients with metastatic neuroendocrine tumors and carcinoid symptoms refractory to available ...